MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/jgh.15936

Медицинская библиотека · Journal of gastroenterology and hepatology · 2022

The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.

Lin Chih-Lin, Tai Chi-Ming, Huang Jee-Fu, Liu Chun-Jen, Chen Hui-Fen, Cheng Pin-Nan, Chen Chi-Yi, Peng Cheng-Yuan, Wang Chia-Chi, Weng Shih-Han, Tseng Tai-Chung, Kao Jia-Horng

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIM: The aim of this study was to assess the impact of body mass index (BMI) on the clinical and histological characteristics of patients with nonalcoholic fatty liver disease (NAFLD).

METHODS

Patients with clinically diagnosed NAFLD who received liver biopsy were retrospectively enrolled from 2007 to 2019. For comparison, all of the patients were divided into lean body mass (< 23 kg/m2 ), overweight (23-24.9 kg/m2 ), and obesity (BMI ≧ 25 kg/m2 ).

RESULTS

A total of 572 patients with histologically confirmed NAFLD, including 40 (6.99%) lean body mass, 54 (9.44%) overweight, and 478 (83.57%) obese patients, were recruited. Obese NAFLD patients had significantly higher grade of steatosis (grade 3: 29.92% vs 22.22% vs 12.5%, P < 0.0001) and hepatocyte ballooning (grade 2: 14.85% vs 12.96% vs 12.5%, P < 0.0001) than overweight and lean NAFLD patients. The prevalence of nonalcoholic steatohepatitis (NASH) was 22.5%, 25.93%, and 36.19% in lean, overweight, and obese NAFLD patients, respectively. Obesity was significantly associated with fibrosis severity (P = 0.03). The fibrosis index based on four factors (FIB-4) score can identify NAFLD patients without significant fibrosis or with cirrhosis. The areas under the receiver-operating characteristic curve of FIB-4 score to identify patients without significant fibrosis or with cirrhosis were 0.82 (95% confidence interval [CI]: 0.69-0.96) and 0.87 (95% CI: 0.76-0.99) in lean patients; 0.77 (95% CI: 0.61-0.93) and 0.81 (95% CI: 0.59-1.0) in overweight patients; and 0.77 (95% CI: 0.72-0.82) and 0.89 (95% CI: 0.85-0.92) in obese patients.

CONCLUSIONS

The majority of NAFLD patients are obese, as defined by BMI. Obesity was significantly associated with NASH and hepatic fibrosis severity in patients with NAFLD.

Для цитирования: Lin Chih-Lin, Tai Chi-Ming, Huang Jee-Fu, Liu Chun-Jen, Chen Hui-Fen, Cheng Pin-Nan, Chen Chi-Yi, Peng Cheng-Yuan, Wang Chia-Chi, Weng Shih-Han, Tseng Tai-Chung, Kao Jia-Horng. The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.. Journal of gastroenterology and hepatology. 2022. DOI: 10.1111/jgh.15936.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.